Drug Shortage Report for MINT-DICLOFENAC
| Report ID | 188045 |
| Drug Identification Number | 02475197 |
| Brand name | MINT-DICLOFENAC |
| Common or Proper name | Diclofenac |
| Company Name | MINT PHARMACEUTICALS INC |
| Market Status | DORMANT |
| Active Ingredient(s) | DICLOFENAC SODIUM |
| Strength(s) | 0.1% |
| Dosage form(s) | SOLUTION |
| Route of administration | OPHTHALMIC |
| Packaging size | 10 ml bottle |
| ATC code | S01BC |
| ATC description | ANTIINFLAMMATORY AGENTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2023-03-27 |
| Estimated end date | 2023-10-30 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2023-09-27 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 6575 DAVAND DRIVE MISSISSAUGA, ONTARIO CANADA L5T 2M3 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2023-09-27 | French | Compare |
| v6 | 2023-09-27 | English | Compare |
| v5 | 2023-06-15 | French | Compare |
| v4 | 2023-06-15 | English | Compare |
| v3 | 2023-03-28 | English | Compare |
| v2 | 2023-03-27 | French | Compare |
| v1 | 2023-03-27 | English | Compare |
Showing 1 to 7 of 7